Creating Memory: Vaccines & Immunity

Episode 31: Understanding determinants of T cell responses following respiratory virus infection and vaccination

We talk with Dr. Mark Painter, a postdoctoral fellow at the University of Pennsylvania Perelman School of Medicine, PA, who studies the role of T cells following respirat

Episode 30: Using deep mutational scanning to characterize interactions between influenza and MHC-II

We talk with Dr. Bernadeta Dadonaite, a research associate  at the Fred Hutchinson Cancer Center, WA, who studies interactions between the influenza attachment protein he

Episode 29: Use of structural approaches to develop 'universal' influenza vaccines

We talk with Dr. Julianna Han, a senior staff scientist at the Scripps Research institute, CA, who studies antibody-epitope interactions following human influenza virus i

Episode 28: The importance of primate models to understand CMV vaccine vectors

We talk with Dr. Daniel Malouli, an assistant professor at the Vaccine and Gene Therapy Institute at the Oregon Health and Science University, OR, who studies how virus-h

Episode 27: IRGM1 regulation of host immunity during vaccination

We talk with Dr. Sumanta Naik, a staff scientist in the Department of Molecular Microbiology at Washington University School of Medicine, who is investigating the role of

Episode 26: Harnessing bacterial components for vaccines and therapeutics

We talk with Dr. Mario Feldman, Professor of Microbiology at Washington University School of Medicine in St. Louis, MO who studies the pathogenesis of Acinetobacter and t

Episode 25: Understanding the role of T cells to improve vaccination for respiratory pathogens

We talk with Dr. Daniel Hoft, Director of the Division of Infectious Diseases, Allergy & Immunology and the Center for Vaccine Development at Saint Louis University Schoo

Episode 24: Understanding Tfh cells to improve vaccine-induced antibody responses

We talk with Dr. Michela Locci, Associate Professor of Microbiology at the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA who studies how T fo

Episode 23: Developing novel lipid nanoparticles to improve vaccine-induced immune responses

We talk with Dr. Namit Chaudhary, a postdoctoral researcher in the Department of Immunology & Microbiology at The Scripps Research Institute, CA, who develops new technol

Episode 22: Use of VSV-chimeras to understand emerging virus infection and develop anti-viral countermeasures

We talk with Dr. Zhouming Liu, an assistant professor of Molecular Microbiology at Washington University School of Medicine, MO, who studies mechanisms of La Cross virus

Episode 21: A role for T cells in flavivirus vaccination and pathogenesis

We talk with Dr. Annie Elong Ngono, a research instructor in the Center for Vaccine Innovation at the La Jolla Institute for Immunology, CA, who studies the role of T cel

Episode 20: Understanding broadly protective immune responses to develop pandemic virus vaccines

We talk with Dr. Anass Abbad, a postdoctoral fellow in the Department of Microbiology at the Icahn School of Medicine Mount Sinai, NY who studies humoral immune responses

Episode 19: Using structural immunology to understand protective or pathogenic antibodies

We talk with Dr. Sandhya Bangaru, a staff scientist in the Department of Integrative Structural and Computational Biology at The Scripps Research Institute, CA who uses a

Episode 18: Understanding B cell responses to natural infection to design better vaccines

We talk with Dr. Florian Krammer, the endowed Mount Sinai Professor of Vaccinology at the Icahn School of Medicine, New York, NY and Director of the Ludwig Boltzmann Inst

Episode 17: Using a rodent hepacivirus to uncover a role for iHALT during HCV infection

We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus

Episode 16: Creating healthy local communities to foster local to global impact

We talk with Dr. Sandro Galea, Dean and Professor of the School of Public Health at Washington University in St. Louis, who uses population based sciences to promote heal

Episode 15: Understanding B cell immune responses and memory to guide vaccine design

We talk with Dr. Hedda Wardemann, Division Head of B Cell Immunology at the German Cancer Research Center and Professor at the Medical Faculty of the University of Heidel

Episode 14: Using Reverse Vaccinology 3.0 for Pandemic Preparedness

We talk with Dr. Emanuele Andreano, Head of Serology and Immunology at Fondazione Biotecnopolo di Siena, Italy, who combines immunology, structural biology and artificial

Episode 13: Using structure-based design to develop novel antiviral therapeutics

We talk with Dr. Daniel Wrapp, Assistant Professor Assistant Professor at the Duke Human Vaccine Institute at Duke University School of Medicine, NC, who uses structure-b

Episode 12: Complex carbohydrates - targets for a Klebsiella pneumoniae vaccine

We talk with Dr. Paeton Wantuch, a Staff Scientist in the Department of Pediatrics at Washington University School of Medicine, MO, who uses animal models to understand c